Politics

Navigating the Promise and Peril of Gene Editing with CRISPR

EXECUTIVE SUMMARY  On December 08, 2023, the U.S. Food and Drug Administration (FDA) approved Casgevy and Lyfgenia, the first CRISPR-based treatment for sickle cell disease.   Gene editing marks a major milestone in the potential to cure genetic disorders but, the process has raised many ethical concerns. As gene editing is a relatively recent advancement, there … Continue reading →

Politics

Securing Critical Supply Chains: How New Regulations Are Shaping the Future

EXECUTIVE SUMMARY   The semiconductor industry, projected by the World Semiconductor Trade Statistics (WSTS) to reach approximately $611 billion in value by 2024, is considered the backbone of the Fourth Industrial Revolution, serving as an essential element in modern technology and innovation.  Demand disruptions caused by the COVID-19 pandemic in 2020 caused the overall projected revenue … Continue reading →

Politics

Bracing for Impact: FEMA’s Strategy for Natural Disasters and Economic Fallout 

Executive Summary  The 2023: A historic year of U.S. billion-dollar weather and climate disasters | NOAA Climate.gov  indicates the increasingly detrimental costs of the growing occurrence of natural disasters as the total cost of U.S. billion-dollar disasters over the last 5 years (2019-2023) is $603.1 billion, with a 5-year annual cost average of $120.6 billion,  … Continue reading →